Q3 2025 Earnings Call Transcript October 29, 2025 GSK plc beats earnings expectations. Reported EPS is $1.48, expectations ...
Q3 2025 Earnings Call October 30, 2025 4:30 PM EDTCompany ParticipantsJacquie Ross - Senior Vice President of Treasury ...
Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), is a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections. It announced today ...
KTNV Las Vegas, NV on MSN
HIV Prevention: What You Need to Know
Dr. Jean Van Wyk, Chief Medical Officer at ViiV Healthcare, shares insights on HIV prevention, recent research, and how ...
News-Medical.Net on MSN
Improving tobacco cessation care for people living with HIV
People living with HIV who smoke are currently more likely to die from lung cancer than from HIV-related causes. Two cancer ...
Patients with multidrug resistant HIV infection who switch to a single tablet of bictegravir/emtricitabine/tenofovir ...
Africanews on MSN
South Africa gives twice-yearly HIV prevention jab the green light
It is believed the lenacapavir shot could end HIV/Aids in the country within 14 to 18 years if enough people were to take it.
Oral HIV pre-exposure prophylaxis (PrEP) adoption varies across the US, with posters presented at the Academy of Managed Care Pharmacy Nexus 2025 meeting in National Harbor, Maryland, highlighting ...
Addressing the question of whether and how immune cells (macrophages) in the central nervous system (CNS) traffic out, ...
Sebela Women's Health Inc., a part of Sebela Pharmaceuticals, today announced that the journal Contraception has awarded the publication of Phase 3 data of MIUDELLA® (copper intrauterine system) one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback